Michael Geffner insider trades

Open-market stock purchases and sales by Michael Geffner, Chief Medical Officer at Immunovant, Inc, from SEC Form 4 filings since Jan 26, 2024.

Recent trades

DateStockTradeValue
Oct 22, 2025IMVT Immunovant, IncSold$49.4K
Oct 8, 2025IMVT Immunovant, IncSold$20.7K

Companies traded

  • IMVT Immunovant, Inc: 12 sales, last Oct 22, 2025

Get free alerts when Michael Geffner files a new trade →